Rosetta Genomics Ltd. (USA) (NASDAQ:ROSG)

CAPS Rating: 2 out of 5

The Company is seeking to develop and commercialize new diagnostic and therapeutic products based on a recently discovered group of genes known as microRNAs.

Recs

0
Player Avatar pchop123 (76.58) Submitted: 9/4/2012 1:09:46 PM : Underperform Start Price: $5.60 ROSG Score: +5.56

dump on any sign of strength

Featured Broker Partners


Advertisement